The digital innovation in surgery presents a trend of precise, minimally invasive, and personalized features. This workshop aims to address the challenges by gathering, training and connecting the Early Career Researchers (ECRs) from different disciplines for better understanding of the complexity and contexts related to surgery technology and working together to develop impactful research projects, facilitated through the training from mentors and new joint research. The workshop will provide an excellent platform for both UK and Chinese ECRs to expand their research and stimulate collaboration on research and development, technology transfer and commercialization between UK and China.
Under the Researcher Links scheme (offered within the Newton Fund), Beihang University will be holding the workshop on the above theme in Liaoning Hotel Beijing on 16-18 October 2019. The workshop is being coordinated by Dr. Xiaosong Yang and Prof. Junjun Pan, and will have contributions from other leading researchers. We are now inviting ECRs from the UK or China to apply to attend this workshop. All travel and accommodation expenses will be covered by the Newton Fund Researcher Links programme. The application form, with more details on the initiative, can be found at https://displast.bournemouth.ac.uk/ and should be sent to xyang@bournemouth.ac.uk by an email titled “Researcher Links Workshop” before the deadline of 15 July 2019.











Prof Marahatta promoting BU-Nepal collaboration
3C Online Social: Research Culture, Community & Can you Guess Who? Thursday 26 March 1-2pm
Final Call: UKCGE Recognised Research Supervision Programme – Deadline Monday 16 March
Interdisciplinary research: Not straightforward?
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease